Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Colorcon
Cipla
Teva
Healthtrust
US Army
Chinese Patent Office
Accenture
Dow

Generated: April 20, 2018

DrugPatentWatch Database Preview

CEREBYX Drug Profile

« Back to Dashboard

When do Cerebyx patents expire, and what generic alternatives are available?

Cerebyx is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in CEREBYX is fosphenytoin sodium. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fosphenytoin sodium profile page.
Drug patent expirations by year for CEREBYX
Synonyms for CEREBYX
(SP-4-2)-5,5-Diphenyl-3-((phosphonooxy)methyl)-2,4-imidazolidinedione disodium salt
2,4-Imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, disodium salt
3-(Hydroxymethyl)-5,5-diphenylhydantoin, disodium phosphate (ester)
3B1-009062
5,5-diphenyl-3-[(phosphonooxy)methyl]-2,4-imidazolidinedione disodium salt
5,5-Diphenyl-3-[(phosphonooxy)methyl]-2,4-imidazolidinedione disodium salt hydrate
5,5-Diphenyl-3-[(phosphonooxy)methyl]-2,4-imidazolidinedione Sodium Salt
5,5-diphenyl-3-[[[di(sodiooxy)phosphinyl]oxy]methyl]-1h-imidazole-2,4(3h,5h)-dione
7VLR55452Z
92134-98-0
93390-81-9 (Parent)
A844152
AC-1705
AC1L1KUL
ACC 9653
ACC 9653-010
ACC-9653
ACC-9653-010
ACC-9653-010 (sodium salt)
AK343791
AKOS015915510
AN-14696
AOB2862
API0009133
BC210114
C16H13N2Na2O6P
Cerebyx (TN)
Cetebyx
CHEMBL919
CI 982
CI-982
CS-7116
CTK8F9934
D02096
disodium (2,5-dioxo-4,4-diphenyl-1-imidazolidinyl)methyl phosphate
disodium (2,5-dioxo-4,4-diphenyl-imidazolidin-1-yl)methyl phosphate
disodium (2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate
disodium [2,5-bis(oxidanylidene)-4,4-diphenyl-imidazolidin-1-yl]methyl phosphate
disodium;(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate
DR002404
DTXSID1044271
fospenytoin
fosphenytion sodium
Fosphenytoin (disodium)
Fosphenytoin disodium
Fosphenytoin disodium salt
Fosphenytoin inverted exclamation mark inverted exclamation markSodium
Fosphenytoin sodium
fosphenytoin sodium (250 mg)
Fosphenytoin sodium (USP)
Fosphenytoin sodium [USAN:USP]
Fosphenytoin sodium [USAN]
Fosphenytoin_Sodium
fosphenytoin, disodium salt
Fosphenytoinsodium
Fostoin
FT-0630980
GQPXYJNXTAFDLT-UHFFFAOYSA-L
HE415617
HE417548
HY-B1657A
I14-6454
KM3079
LS-178162
MFCD20527322
NPC-06
Phosphenytoin sodium
Pro-Epanutin
SCHEMBL119417
Sodium (2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate
ST51055423
UNII-7VLR55452Z
VA10978

US Patents and Regulatory Information for CEREBYX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis CEREBYX fosphenytoin sodium INJECTABLE;INJECTION 020450-001 Aug 5, 1996 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CEREBYX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke Davis CEREBYX fosphenytoin sodium INJECTABLE;INJECTION 020450-001 Aug 5, 1996 ➤ Sign Up ➤ Sign Up
Parke Davis CEREBYX fosphenytoin sodium INJECTABLE;INJECTION 020450-001 Aug 5, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Merck
UBS
Accenture
McKesson
Queensland Health
Deloitte
Farmers Insurance
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.